Skip to main content

Table 2 An overview of lncRNAs involved in prostate cancer progression/inhibition

From: Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention

LncRNA

Signaling network

Remarks

Refs

UNC5B-AS1

Caspase-9

Enhanced expression of UNC5B in prostate cancer cells and tissues

Negative association between UNC5B-AS1 and caspase-9 and presence of negative feedback loop

Preventing apoptosis

[338]

GASL1

GLUT1

Significant difference in GASL1 expression in normal and prostate cancer tissues

Reducing GLUT1 expression and increasing Bcl-2 expression

Overexpression of GASL1 suppresses tumor growth and invasion

[339]

GAS5

-

Exposing prostate cancer cells to dexamethasone enhances expression level of GAS5 to suppress proliferation and stimulate cell cycle arrest

[340]

EMX2OS

cGMP/PKG

Low expression of EMX2OS in prostate cancer, revealing its tumor-suppressor role

Overexpression of EMX2OS and TCF12 jointly induces cGMP/PKG pathway to inhibit growth and viability of cancer cells

[341]

UCA1

MDM2/E-cadherin

Preventing the interaction between MDM2 and E-cadherin

Increasing stability of E-cadherin

Preventing aggressive behavior of prostate cancer cells

[342]

TMPO-AS1

-

This lncRNA can be considered as a prognostic and diagnostic tool in prostate cancer

Overexpression of TMPO-AS1 is associated with undesirable prognosis

Apoptosis inhibition

[343]

NCK1-AS1

-

Overexpression of NCK1-AS1 in prostate cancer and can be utilized for distinguishing with BPH patients

[344]

NR2F2-AS1

CDK4

Acting as tumor-promoting factor

Increasing expression level of CDK4

Mediating cell cycle progression

[345]

GAS5

-

Association of GAS5 with translational elongation, protein biosynthesis and transcription

Apoptosis inhibition

Increasing proliferation and cell cycle progression

[346]

SOCS2-AS1

TNFSF10

Upregulation of SOCS2-AS1 in prostate cancer

Down-regulation of TNFSF10 by lncRNA

Apoptosis inhibition

[347]

HOTAIR

-

HOTAIR can drive neuroendocrine differentiation of prostate cancer

[348]

POTEF-AS1

-

Increasing growth and cell cycle progression

Inhibiting apoptosis via down-regulating TLR pathway

Mediating docetaxel resistance via suppressing apoptosis

[349]

MIR4435-2HG

FAK/Akt/β-catenin

Overexpression of MIR4435-2HG in prostate cancer cells and tissues

Silencing this lncRNA prevents proliferation and invasion

MIR4435-2HG cooperates with ST8SIA1 to induce FAK/Akt/β-catenin signaling, leading to prostate cancer progression

[350]

SNHG1

hnRNPL/EMT

Interaction of SNHG1 with hnRNPL to induce EMT in prostate cancer via E-cadherin down-regulation and vimentin upregulation

Increasing migration and metastasis of cancer cells

[351]

ARLNC1

AR

Upregulation of ARLNC1 by AR

ARLNC1 can also promote AR stabilization via RNA-RNA interaction

Increasing prostate cancer progression

[352]

LBCS

hnRNPK/AR

Interaction of LBCS with hnRNPK to suppress AR translation

Low expression of LBCS is associated with poor prognosis

Preventing castration resistance in prostate cancer

[353]